Cargando…

Safety of Four COVID-19 Vaccines across Primary Doses 1, 2, 3 and Booster: A Prospective Cohort Study of Australian Community Pharmacy Vaccinations

Four COVID-19 vaccines are approved for use in Australia: Pfizer-BioNTech BNT162b2 (Comirnaty), AstraZeneca ChAdOx1 (Vaxzevria), Moderna mRNA-1273 (Spikevax) and Novavax NVX-CoV2373 (Nuvaxovid). We sought to examine adverse events following immunisation (AEFI) at days 3 and 42 after primary doses 1,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salter, Sandra M., Li, Dani, Trentino, Kevin, Nissen, Lisa, Lee, Kenneth, Orlemann, Karin, Peters, Ian, Murray, Kevin, Leeb, Alan, Deng, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786585/ https://www.ncbi.nlm.nih.gov/pubmed/36560426 http://dx.doi.org/10.3390/vaccines10122017

Ejemplares similares

Active vaccine safety surveillance of seasonal influenza vaccination via a scalable, integrated system in Western Australian pharmacies: a prospective cohort study
por: Salter, Sandra, et al.
Publicado: (2021)

Immediate Adverse Events Following COVID-19 Vaccination in Australian Pharmacies: A Retrospective Review
por: Gallo, Alexander T., et al.
Publicado: (2022)

Making a SmartStart for peanut introduction to support food allergy prevention guidelines for infants
por: Vale, Sandra L., et al.
Publicado: (2023)

SmartStartAllergy: a novel tool for monitoring food allergen introduction in infants
por: O'Sullivan, Michael, et al.
Publicado: (2020)

COVID-19 booster vaccination in rural community pharmacies
por: Gamble, Abigail, et al.
Publicado: (2023)

The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample
por: Barnes, K., et al.
Publicado: (2023)

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine
por: Litt, John, et al.
Publicado: (2020)

Vaccines in the Pharmacies?
por: Verna, Roberto
Publicado: (2021)

Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
por: Gabutti, Giovanni, et al.
Publicado: (2014)

Availability of the HPV Vaccine in Regional Pharmacies and Provider Perceptions Regarding HPV Vaccination in the Pharmacy Setting
por: Maples, Jill M., et al.
Publicado: (2022)

Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study
por: Watkins, Kim, et al.
Publicado: (2016)

Examining General Vaccine Acceptance and COVID-19 Vaccine Intention: Comparison across Pharmacies in California and Ohio
por: Mercadante, Amanda R., et al.
Publicado: (2023)

Pharmacy Management of Vaccines
por: Cannon, H. Eric
Publicado: (2007)

Testing persuasive messages about booster doses of COVID-19 vaccines on intention to vaccinate in Australian adults: A randomised controlled trial
por: Steffens, Maryke S., et al.
Publicado: (2023)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Immunisation provider experiences with an automated short message service-based active surveillance system for monitoring adverse events following immunisation: A qualitative descriptive study
por: Singh, Gurkamal, et al.
Publicado: (2021)

Course experiences, satisfaction and career intent of final year pre-registration Australian pharmacy students
por: Shen, Grace, et al.
Publicado: (2014)

Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis
por: Bayliss, Julianne, et al.
Publicado: (2020)

Vaccine and Psychological Booster: Factors Associated With Older Adults’ Compliance to the Booster COVID-19 Vaccine in Israel
por: Ben-David, Boaz M., et al.
Publicado: (2022)

Booster Covid Vaccination- Luxury or Need?
por: Karn, Mitesh, et al.
Publicado: (2021)

The necessity of booster vaccination after neonatal hepatitis B vaccination
por: Lankarani, Kamran Bagheri
Publicado: (2011)

Neighborhood-level COVID vaccination and booster disparities: A population-level analysis across California
por: Oh, Debora L., et al.
Publicado: (2023)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
por: Bayliss, Julianne, et al.
Publicado: (2020)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries
por: Versteegen, Pauline, et al.
Publicado: (2022)

Pharmacist's Perspectives on Administering a COVID-19 Vaccine in Community Pharmacies in Four Balkan Countries
por: Turcu-Stiolica, Adina, et al.
Publicado: (2021)

Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series
por: Tan, Kevin Y. K., et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
Publicado: (2023)

Booster or additional vaccination doses in patients vaccinated against COVID-19
por: García-Botella, Alejandra, et al.
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

The COVID-19 Vaccine: Why Should I Get the Vaccines and the Boosters?
por: Zanwar, Preeti Pushpalata, et al.
Publicado: (2023)

A national survey exploring oral healthcare service provision across Australian community pharmacies
por: Freeman, Christopher R, et al.
Publicado: (2017)

Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study
por: Bor, Jacob, et al.
Publicado: (2023)

Patient Perceptions on Receiving Vaccination Services through Community Pharmacies
por: Kowalczuk, Anna, et al.
Publicado: (2022)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

COVID-19 vaccine equity and booster doses
por: The Lancet Infectious Diseases
Publicado: (2021)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

COVID-19-booster vaccine-induced encephalitis
por: Sluyts, Yasmine, et al.
Publicado: (2022)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kc0gndrbnnjb3h9ake0ev5dphf